HomeCancer

Cancer

Roche to halt lung most cancers trial

12:40 04/07/24 Max: 26,740.00 Min: 26,420.00 Roche is to finish a novel lung most cancers remedy trial, the Swiss firm...

FDA Grants Quick Monitor Designation to SYNC-T SV-102 for Metastatic Castration-Resistant Prostate Most cancers

The FDA has granted quick observe designation to SYNC-T SV-102 remedy (Syncromune Inc.) for the therapy of metastatic castration-resistant prostate most cancers (mCRPC)....

Group rallies round Georgetown household, raises almost $60K for teen’s bone most cancers therapies

Household, buddies, and group members have raised almost $60,000 on GoFundMe in current months for a younger Georgetown man who has been combating...

In Acute Leukemia, Probability of Response Is Affected person’s Prime Concern

For sufferers with acute leukemia, an important think about selecting a remedy within the relapsed or refractory setting is the prospect of a...

Hot Topics